Literature DB >> 9266500

The diversity of coenzyme Q function.

F L Crane1, P Navas.   

Abstract

Coenzyme Q is uniquely designed as an electron and proton carrier within the lipid phase of membranes. It now appears that this unique chemistry has diverse application to important functions in all cellular membranes. The first function of coenzyme Q was defined in the energy transduction process in mitochondria. New studies show that the presence of coenzyme Q in other cellular membranes has dynamic rather than passive significance. Coenzyme Q functions in the plasma membrane electron transport involved in activation of signalling protein kinases related to gene activation for cellular proliferation. Furthermore, the antioxidant potential of the reduced coenzyme Q is now taken on a new significance in the evidence that the reduced quinone can act to maintain tocopherol in the reduced state in membranes and ascorbate reduced both inside and outside the cell.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266500     DOI: 10.1016/s0098-2997(97)00016-2

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  16 in total

1.  A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Authors:  Glenn J Lesser; Doug Case; Nancy Stark; Susan Williford; Jeff Giguere; L Astrid Garino; Michelle J Naughton; Mara Z Vitolins; Mark O Lively; Edward G Shaw
Journal:  J Support Oncol       Date:  2013-03

2.  Genetics of coenzyme q10 deficiency.

Authors:  Mara Doimo; Maria A Desbats; Cristina Cerqua; Matteo Cassina; Eva Trevisson; Leonardo Salviati
Journal:  Mol Syndromol       Date:  2014-07

3.  Preliminary evidence on existence of transplasma membrane electron transport in Entamoeba histolytica trophozoites: a key mechanism for maintaining optimal redox balance.

Authors:  Tanmoy Bera; Nilay Nandi; D Sudhahar; Md Ali Akbar; Abhik Sen; Pradeep Das
Journal:  J Bioenerg Biomembr       Date:  2006-12       Impact factor: 2.945

4.  A family segregating lethal neonatal coenzyme Q10 deficiency caused by mutations in COQ9.

Authors:  Amanda C Smith; Yoko Ito; Afsana Ahmed; Jeremy A Schwartzentruber; Chandree L Beaulieu; Erika Aberg; Jacek Majewski; Dennis E Bulman; Karina Horsting-Wethly; Diana Vermunt-de Koning; Richard J Rodenburg; Kym M Boycott; Lynette S Penney
Journal:  J Inherit Metab Dis       Date:  2018-03-20       Impact factor: 4.982

5.  alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation.

Authors:  P Klivenyi; E Karg; C Rozsa; R Horvath; S Komoly; I Nemeth; S Turi; L Vecsei
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

6.  Involvement of thermoplasmaquinone-7 in transplasma membrane electron transport of Entamoeba histolytica trophozoites: a key molecule for future rational chemotherapeutic drug designing.

Authors:  Nilay Nandi; Tanmoy Bera; Sudeep Kumar; Bidyut Purkait; Ashish Kumar; Pradeep Das
Journal:  J Bioenerg Biomembr       Date:  2011-04-27       Impact factor: 2.945

7.  Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis.

Authors:  A Domnica Fotino; Angela M Thompson-Paul; Lydia A Bazzano
Journal:  Am J Clin Nutr       Date:  2012-12-05       Impact factor: 7.045

Review 8.  Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.

Authors:  Maria Andrea Desbats; Giada Lunardi; Mara Doimo; Eva Trevisson; Leonardo Salviati
Journal:  J Inherit Metab Dis       Date:  2014-08-05       Impact factor: 4.982

Review 9.  Coenzyme Q, oxidative stress and aging.

Authors:  Rajindar S Sohal; Michael J Forster
Journal:  Mitochondrion       Date:  2007-03-30       Impact factor: 4.160

Review 10.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.